Healthtech Investors & VC Firms
3408 firms in this list, with a median first check of $500K. 737 of them lead rounds. Generated from verified public data and updated continuously.
Patamar Capital
JakartaSeed–Series B
14 people
Overline
AtlantaPre-Seed–Series A$250K – $1.5M
26 people
Robin Hood Ventures
PhiladelphiaSeed–Late Stage$250K – $1M
2 people
DNA Capital
São PauloPre-Seed–Late Stage$100K – $5M
16 people
Northlane Capital Partners
BethesdaGrowth$25M – $150M
4 people
Revent
BerlinPre-Seed–Series A$500K – $3M
10 people
Samvid Ventures
Pre-Seed–Seed$100K – $500K
4 people
TA Ventures
Frankfurt am MainPre-Seed–Series A$100K – $1M
10 people
White Fund
LiègeSeed–Series B$2.2M – $5.4M
16 people
Zinc
LondonPre-Seed–Seed
16 people
CTI Life Sciences Fund L.P.
MontréalSeed–Late Stage
9 people
Lotux Ventures
MexicoPre-Seed$50K – $100K
15 people
Merida Capital Holdings
RyeSeries B–Late Stage
6 people
NovaCapital
Seed–Late Stage
9 people
SciFi VC
San FranciscoPre-Seed–Series B$100K – $1M
6 people
Brightstone Venture Capital
MinneapolisSeed–Late Stage$250K – $10M
11 people
HealthQuad
New DelhiSeed–Series C
17 people
Indico Capital Partners
LisbonSeed–Growth$250K – $10M
8 people
Invivo Capital Partners
BarcelonaPre-Seed–Series A$2.2M – $4.3M
11 people
Mérieux Equity Partners
ParisSeed–Late Stage$3.2M – $86M
14 people
Vertex Growth
SingaporeSeries A–Growth
17 people
Bonitás Ventures
BudapestSeries A–Late Stage$540K – $4.3M
19 people
Finance Yorkshire
BarnsleySeed–Growth
22 people
Inertia Ventures
New YorkSeed–Series A$2M
4 people
Related lists
Investors & VC Firms in North America (13808)Investors & VC Firms in United States (12951)Investors & VC Firms in Europe (5511)Crypto & Web3 Investors & VC Firms (4813)Investors & VC Firms in Global (4134)SaaS Investors & VC Firms (3860)AI & Machine Learning Investors & VC Firms (3764)Fintech Investors & VC Firms (3709)Investors & VC Firms in Asia-Pacific (3560)Enterprise Software Investors & VC Firms (3215)
Data sourced from public filings and firms' own websites — see our methodology.





























































































